Results 51 to 60 of about 1,361,126 (321)

Systemic anti-inflammatory therapy aided by double-headed nanoparticles in a canine model of acute intraocular inflammation

open access: yesScience Advances, 2020
Orally delivered double-headed nanoparticle curcumin has potential to treat intraocular inflammation. Novel approaches circumventing blood-ocular barriers in systemic drug delivery are lacking.
R. Ganugula   +7 more
semanticscholar   +1 more source

Brolucizumab: Evaluation of Compassionate Use of a Complex Anti-VEGF Therapy

open access: yesClinical Ophthalmology, 2021
Julianna E Murray, Aaron S Gold, Azeema Latiff, Timothy G Murray Private Practice, Miami Ocular Oncology & Retina, Miami, FL, USACorrespondence: Timothy G MurrayMiami Ocular Oncology & Retina, 6705 Red Road Suite 412, Miami, FL, 33143, USAEmail tmurray ...
Murray JE, Gold AS, Latiff A, Murray TG
doaj  

Factors influencing aqueous flare after cataract surgery and its evaluation with laser flare photometry

open access: yesTherapeutic Advances in Ophthalmology, 2023
Despite the refinement of modern cataract surgery, postoperative inflammation still constitutes a substantial amount of visual morbidity worldwide. A surrogate for intraocular inflammation and blood–aqueous barrier breakdown can be objectively quantified
Christopher Way   +3 more
doaj   +1 more source

Comparison of Outcomes between Endoscopic and Transcleral Cyclophotocoagulation. [PDF]

open access: yes, 2017
Importance: Traditionally cyclophotocoagulation has been reserved as a treatment of last resort for eyes with advanced stage glaucoma, but increasingly it is offered to eyes with less severe disease.
Beardsley, Robert   +7 more
core   +3 more sources

Severe intraocular inflammation after intravitreal injection of faricimab: a single-site case series of six patients.

open access: yesAmerican journal of ophthalmology-glaucoma
PURPOSE To describe the patient characteristics and clinical course of severe intraocular inflammation (IOI) following intravitreal injection (IVT) of faricimab. DESIGN Retrospective case series. METHODS Case series at a single French academic center
Inès Ben Ghezala   +6 more
semanticscholar   +1 more source

Steroid-eluting contact lenses for corneal and intraocular inflammation.

open access: yesActa Biomaterialia, 2020
Ocular inflammation is one of the leading causes of blindness worldwide, and steroids in topical ophthalmic solutions (e.g. dexamethasone eye drops) are the mainstay of therapy for ocular inflammation. For many non-infectious ocular inflammatory diseases,
Lokendrakumar C. Bengani   +10 more
semanticscholar   +1 more source

A Review of Innovations in Rhegmatogenous Retinal Detachment Surgical Techniques. [PDF]

open access: yes, 2017
Rhegmatogenous retinal detachment (RRD) requires surgical intervention for its repair. There are variable techniques used for this purpose, and they are all being continuously refined.
Loewenstein, Anat   +4 more
core   +3 more sources

Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review

open access: yesInternational Journal of Retina and Vitreous, 2021
Background Intraocular inflammation is an uncommon but potentially vision-threatening adverse event related to anti-VEGF therapy. This is of increasing importance given both the volume of injections performed, as well as the increased prevalence of ...
William J. Anderson   +5 more
doaj   +1 more source

Polymerase chain reaction in ocular and adnexal inflammation: Our experience with review of literature

open access: yesTNOA Journal of Ophthalmic Science and Research, 2021
Polymerase chain reaction (PCR) is a revolutionary innovation involving enzymatic amplification of nucleic acid sequences in repeated cycles of denaturation, oligonucleotide annealing, and DNA polymerase extension.
Arkaprava Pradhan   +2 more
doaj   +1 more source

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy

open access: yesBiomedicines, 2021
We compared the short-term outcomes between 3-monthly aflibercept and brolucizumab injections for treatment-naïve polypoidal choroidal vasculopathy (PCV). A total of 52 eyes were included.
Yoshiko Fukuda   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy